Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. - Wikidata - awgldk - TriplyDB

Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial.

Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial.

http://www.wikidata.org/entity/Q42483132

about

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient Stem cell transplantation for ischemic stroke Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury Mesenchymal stem cells in regenerative rehabilitation Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke Clinical imaging in regenerative medicine Stem cell imaging: from bench to bedside Stem cell therapy for acute cerebral injury: what do we know and what will the future bring?High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke Cell based therapies for ischemic stroke: from basic science to bedside Stem cells in human neurodegenerative disorders--time for clinical translation?Developing Cellular Therapies for Stroke Engraftment of nonintegrating neural stem cells differentially perturbs cortical activity in a dose-dependent manner.Current status of cell therapies in stroke.Optimizing the success of cell transplantation therapy for stroke.Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke.Prevention of senescence progression in reversibly immortalized human ensheathing glia permits their survival after deimmortalization.Neural repair and neuroprotection with stem cells in ischemic stroke.Preclinical Studies and Translational Applications of Intracerebral Hemorrhage.Role of neural precursor cells in promoting repair following stroke.Curiosity and cure: translational research strategies for neural repair-mediated rehabilitation Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients.Stem cells for ischemic brain injury: a critical review.The strong financial case for regenerative medicine and the regen industry.Trophic factors and stem cells for promoting recovery in stroke.Robotics, stem cells, and brain-computer interfaces in rehabilitation and recovery from stroke: updates and advances.Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability.Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.Preclinical assessment of stem cell therapies for neurological diseases.Stem cells and stroke: opportunities, challenges and strategies Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in mice Stem cell-like dog placenta cells afford neuroprotection against ischemic stroke model via heat shock protein upregulation.Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain Ethical perspectives on knowledge translation in rehabilitation.Manufacturing neurons from human embryonic stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy Combining BMI Stimulation and Mathematical Modeling for Acute Stroke Recovery and Neural Repair Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI.

P2860

Q21090134-5A4D47AB-415C-4C6E-89D4-855609AD57DD Q24235315-B8FF7296-61C6-445C-952C-522995D2C259 Q24563160-48737884-E6EF-4AB9-AA17-B5EC81900017 Q26743836-166F084A-264C-485F-BDFA-2F8D937F1CCF Q26800178-77504067-F7D1-4742-A9B2-35E074B6E601 Q26800181-14878EF5-DBEB-4B72-998A-E3A298AC6137 Q26851906-4A71E567-65A3-482F-B672-B424CEF0AB2C Q26861615-83D7F041-1025-4754-901E-FF329A99C912 Q26866149-C5EF6042-5A0A-4F5A-80FB-9BC87D2BD14E Q27008225-164DE5E1-898B-4EF1-833E-BD858FC88BFB Q27025754-8886BE50-8629-47F6-9A87-E3229BB03E74 Q27687068-3BECDA4F-D770-49DC-8F6F-B55D0E903EB9 Q28087451-6ACBDD4B-5AF2-4BCF-B3B0-F584F687124B Q30559499-C0CD9944-049F-4936-B38F-7C903A0E02FC Q33614825-F1484F6F-0FB9-4935-9067-FE61A4BF60E7 Q33636930-6DA81404-B63C-45C2-B8C0-9F462B2B2848 Q33694696-DBEB8B0D-1859-4EA0-9018-27D6810169AC Q33730711-927D5D84-9403-4C09-8202-EB690D3EC3FE Q33772112-B5EB59A2-DA52-41F9-BE76-D06BC43A8DE3 Q33862295-FCA7F6AD-F005-41AC-AE1F-EE91E77ACDD2 Q33862328-9B68C1F4-FF79-4547-89A8-6A9B44AEA4FF Q33904296-A7EFBB1B-6B98-4C0E-819D-20121C04FD75 Q33904790-B8781B9B-0086-4485-8C2C-D199AD4D004B Q33957236-519AB4B1-08D8-410D-AB2A-80F77321697E Q34011549-6AA569A8-F0F6-4A50-9433-441F3517DB76 Q34240109-E3AEBB2A-0FF7-4F9E-ABAC-15A40B0BC304 Q34340851-6B2E78C6-BDE6-4EFF-AFCA-69BBA8F421DB Q34419548-5318D21A-AE6D-4128-B712-AF9CD9DD2EAD Q34428957-8B7138CE-6D7F-4AA2-B489-460029B71D3E Q34595662-5300B81A-711F-4328-AE73-6E8E0F6B35ED Q34786764-4BFAE909-02D6-428E-B544-9D2C89AE3AB5 Q34923168-EE680F7B-CA17-4D21-974C-EEE93A49F8B9 Q34984321-29F1D04C-E3EA-44A3-B1BE-3C7FC666DB81 Q35006313-CF603885-62DC-493C-B3F1-5FE188EF881C Q35007872-03D86D26-0FA5-4519-92B4-D8482DA9655A Q35077499-79E9C7EB-AFC7-4811-AF87-1E33A120A563 Q35111696-A58AD3AB-94FC-4E7A-A31D-254FB2282774 Q35130257-6EFDAA32-02F7-4754-8958-B6A24F492BE9 Q35648103-F2967EFD-3A20-4357-B571-84BFF78FFB6A Q35840475-35A30837-5952-4FB7-B158-64F3B426E7EA

P2860

Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial.

http://www.wikidata.org/entity/Q42483132

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Neurotransplantation for patie ...... e: a phase 2 randomized trial.

@en

Neurotransplantation for patie ...... e: a phase 2 randomized trial.

@nl

type

label

Neurotransplantation for patie ...... e: a phase 2 randomized trial.

@en

Neurotransplantation for patie ...... e: a phase 2 randomized trial.

@nl

prefLabel

Neurotransplantation for patie ...... e: a phase 2 randomized trial.

@en

Neurotransplantation for patie ...... e: a phase 2 randomized trial.

@nl

P1433

Q42483132-C8175FAB-84C0-4339-BFB7-C615DACCD363

P1476

Q42483132-34A6D0C6-82F4-45C8-B099-77EEA5BDB5F8

P2093

Q42483132-11075500-11AC-4EAC-96D3-DDB2208C8334

Q42483132-1DA03912-3643-4F7F-B694-FF355A153C06

Q42483132-209A7EA8-2A47-4CAF-86AA-47DF87824437

Q42483132-450D079B-B7FD-48D9-AB5F-49383AA37417

Q42483132-6A10AE78-2175-4BBF-A987-63273F565102

Q42483132-6FD09CE2-E111-4829-B3E7-5A41AEEA4B9F

Q42483132-730B1FEF-98D3-4707-952F-CCA0216FD080

Q42483132-744EB820-FB26-4E61-965F-339D2ED2CA17

Q42483132-7FAC5F78-014C-4653-B4B5-D5D51E234DD3

Q42483132-8B042A1B-4915-4703-880C-0D74342F7EBC

P304

Q42483132-E1D3EF9A-DFCA-4137-9784-BAE5D863D474

P31

Q42483132-3132809B-719D-406D-8B7A-E1FF478AAC64

P356

Q42483132-ABADB142-0109-4AB7-B9CD-6C4B99E88929

P407

Q42483132-5E7D762D-79A1-464F-9A83-79F581B9C516

P433

Q42483132-6549C6C9-E0AB-4B8A-88B8-AB39E345E0C2

P478

Q42483132-DE703CBD-0710-4975-A6B3-5038A9384DE3

P50

Q42483132-E7ADE724-D065-42BE-8198-1082C04AFAE8

P577

Q42483132-E5C6BCD1-94C9-477E-B966-E89612186E1A

P5875

Q42483132-4070CF72-9DFD-4722-AA00-7BB3B4634C2F

P698

Q42483132-769AEB0A-CB1C-487F-AB78-973A3D0FD4EA

P921

Q42483132-8537B6FA-6459-4CAE-9E05-221DA88D7E2A

P356

JNS.2005.103.1.0038

P1433

Journal of Neurosurgery

P1476

Neurotransplantation for patie ...... e: a phase 2 randomized trial.

@en

P2093

Carolyn C Meltzer

http://www.w3.org/2001/XMLSchema#string

Catriona Jamieson

http://www.w3.org/2001/XMLSchema#string

David Tong

http://www.w3.org/2001/XMLSchema#string

Desiree Luu

http://www.w3.org/2001/XMLSchema#string

Elaine Elder

http://www.w3.org/2001/XMLSchema#string

Gary K Steinberg

http://www.w3.org/2001/XMLSchema#string

James Gebel

http://www.w3.org/2001/XMLSchema#string

Jeffrey Teraoka

http://www.w3.org/2001/XMLSchema#string

John C Flickinger

http://www.w3.org/2001/XMLSchema#string

Jonathan Lebowitz

http://www.w3.org/2001/XMLSchema#string

P304

38-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3171/JNS.2005.103.1.0038

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Douglas Kondziolka

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7638707

http://www.w3.org/2001/XMLSchema#string

P698

16121971

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial